Literature DB >> 28232290

Adolescents with cannabis use disorders: Adaptive treatment for poor responders.

Yifrah Kaminer1, Christine McCauley Ohannessian2, Rebecca H Burke3.   

Abstract

OBJECTIVE: Treatment response as measured by both retention and abstinence attainment rates for adolescents with cannabis use disorders (CUD) has been unsatisfactory. This study tested the hypothesis that adaptive treatment (AT) will improve outcomes for poor responders (PR) to evidence-based practice interventions.
METHOD: A total of 161 adolescents, 13-18years of age, diagnosed with DSM-IV CUD, enrolled in this outpatient, randomized, AT study. Following a 7-session weekly motivational enhancement and cognitive behavioral therapy intervention (MET/CBT-7) only poor responders (defined as failing to achieve abstinence at week seven for any reason) were randomized into a 10-week AT phase of either an individualized enhanced CBT or an Adolescent Community Reinforcement Approach (ACRA) intervention. Good responders (GR) enrolled only in follow-up assessments starting at the completion of the AT phase (week 17).
RESULTS: Eighty adolescents (50%) met the criterion for poor response to treatment. Thirty seven percent of poor responders completed the AT phase and 27% of them achieved abstinence. There was no significant difference in retention and abstinence rates between the AT conditions. Although the majority of GR relapsed by week 17, they significantly differed from PR both for drug use (71% vs. 91%, respectively; p<0.05) and reporting to scheduled assessment on that week (78% vs. 54%, respectively; p<0.01).
CONCLUSION: Continuity of care to achieve abstinence among poor responders remains a therapeutic necessity and a research challenge. Examining innovative AT designed interventions including potential integrative approaches should be further studied in order to improve treatment outcomes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescents; Cannabis use disorders; Continued care, adaptive treatment; Poor responders; Treatment outcome

Mesh:

Year:  2017        PMID: 28232290     DOI: 10.1016/j.addbeh.2017.02.013

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  7 in total

1.  Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

Authors:  Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

2.  Barriers for recruitment to treatment of youths with co-occurring substance use disorders and depression.

Authors:  Yifrah Kaminer; Grace Chan; Rebecca Burke
Journal:  Am J Addict       Date:  2022-06-28

3.  Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, 2014-2017: Outcomes, Treatment Delivery, and Promising Horizons.

Authors:  Aaron Hogue; Craig E Henderson; Sara J Becker; Danica K Knight
Journal:  J Clin Child Adolesc Psychol       Date:  2018-06-12

Review 4.  Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies.

Authors:  Matthew C Fadus; Lindsay M Squeglia; Emilio A Valadez; Rachel L Tomko; Brittany E Bryant; Kevin M Gray
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

5.  Retention and Treatment Outcome of Youth with Cannabis Use Disorder Referred By the Legal System.

Authors:  Yifrah Kaminer; Christine Ohannessian; Rebecca Burke
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2019-05

6.  Impact of Continuing Care on Recovery From Substance Use Disorder.

Authors:  James R McKay
Journal:  Alcohol Res       Date:  2021-01-21

7.  Adaptive Treatment for Youth With Substance Use and Depression: Early Depression Response and Short-term Outcomes.

Authors:  John F Curry; Yifrah Kaminer; David B Goldston; Grace Chan; Karen C Wells; Rebecca H Burke; Adrienne Banny Inscoe; Allison E Meyer; Shayna M Cheek
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-08-06       Impact factor: 8.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.